explore
Previous article:
Bright Health sells Medicare Advantage business to Molina
Next article: Vertex cell therapy lets patients with type 1 diabetes stop insulin
Next article: Vertex cell therapy lets patients with type 1 diabetes stop insulin
knowledge
explore
-
AstraZeneca lung cancer study comes in below expectations
2025-09-27 09:45 -
Long Covid research funding gets a major boost from NIH
2025-09-27 09:20 -
The wait for US passports is creating travel purgatory and snarling summer plans
2025-09-27 09:02 -
Tome Biosciences co
2025-09-27 08:13 -
Latigo launches with $135 million for Vertex
2025-09-27 08:05 -
Archived: an online chat discussing Ebola, vaccines, and a new epidemic
2025-09-27 07:46